Scroll for more
Glioma MR Imaging 2.0
COST ACTION CA18206 Know more
Scroll for more
50 000 new cases of glioma per year in Europe PATIENTS Know more
Scroll for more
For initial diagnosis, treatment response assessment, and adverse effect monitoring GLIOMA MR IMAGING Know more
Scroll for more
Currently no open calls GRANTS Know more

Working Groups

In GliMR, we aim to achieve our goals by collaboration within and across five working groups:

WG1 – Advanced MRI biomarkers for glioma characterisation

Working Group 1 focusses on coordinating the identification and quantification of advanced MRI biomarkers for the application in the field of glioma.

WG2 – Multi-site data integration

Working Group 2 coordinates multi-site data integration and enables the creation of large datasets in glioma diagnostics via the creation of common GDPR- and BIDS-compliant forms and data structures.

WG3 – Clinical translation

Working Group 3 focusses on fostering cross-border information exchange about past and current clinical trials and studies of glioma.

WG4 – Stakeholder relations

Working Group 4 ensures representation of all relevant stakeholders within GliMR and acts as liason from GliMR to all relevant stakeholders.

WG5 – Dissemination

Working Group 5 disseminates the Action’s goals and results in tailored manners to all relevant stakeholders.


Latest News

GliMR hosted its first webinar in collaboration with Cercare Medical

GliMR Live Stream at ESMRMB 2020

Congratulations to our Researcher of the Month: Jan Petr

Latest Tweets

Also our member Golestan Karami successfully 👏completed her STSM, despite the COVID-19 pandemic. Golestan can tell you more about her experience on: Check it out! 🖥️ #CA18206 #glimr

Despite the uncertain times, some of our members could finalise their short term scientific missions awarded during the first grant period 👏 Our member Dr. Ruben Nechifor can tell you more about his experience. Check it out! 🖥️
#CA18206 #glimr